计算溶液所需的质量、体积或浓度。
Bevenopran is a peripheral μ-opioid receptor antagonist
In Vivo
Bevenopran is a peripheral μ-opioid receptor antagonist. Bevenopran is currently under investigation for the treatment of opioid-induced bowel dysfunction (OBD) . Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
IC50& Target:μ-opioid receptor
| ALogP | 1.1 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | B654661 |